/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

D

Daniel Simmons

AstraZeneca (United States)(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

35

Papers

131

Citations

6

h-index

5

i10-index

Daniel Simmons is an academic researcher from AstraZeneca (United States). The author has contributed to research in topics: Lung Cancer Treatments and Mutations & PARP inhibition in cancer therapy & Ovarian cancer diagnosis and treatment. The author has an h-index of 6, co-authored 30 publications.

Research Topics

Lung Cancer Treatments and Mutations PARP inhibition in cancer therapy Ovarian cancer diagnosis and treatment BRCA gene mutations in cancer Cancer Genomics and Diagnostics

Papers by this author

works

Validation of an Administrative Claims-based Line of Therapy Algorithm for Women with Ovarian Cancer Using Medical Chart Review

2025 · Advances in Therapy · 3 citations

https://doi.org/10.1007/s12325-025-03174-y

Daniel Simmons John White Valery Walker Stephanie V. Blank

Research topics

topics

Lung Cancer Treatments and Mutations

PARP inhibition in cancer therapy

Ovarian cancer diagnosis and treatment

BRCA gene mutations in cancer

Cancer Genomics and Diagnostics

Chat about Author

Papers

Chat

Click to start Chat